EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Prudential plc
EL7 Factor Analysis
How we score this
Overall76
Strong — clearly above market medianContrarianF 5/7Better than 76% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
81
8.5x▲17.8xTop tier
▸
Growth
87
7.0%7.1%Top tier
▸
Quality
94
——Top tier
▸
Safety
14
——Bottom tier
▸
Capital Return
60
1.05%▼2.12%Around median
▸
Momentum
41
5.4%▲2.9%Around median
▸
Sentiment
50
2▼3Around median
PUK

PUK Prudential plc

Prudential plc · NYSE
Market Closed
26.68
▼ ⁦-0.34%⁩ (-0.09)
Market Cap$33.3B
Beta0.90
52w Low52w High
24.6134.03
Last Week
⁦-2.24%⁩
Last Month
⁦-2.56%⁩
Last 3 Months
⁦+6.68%⁩
Last Year
⁦-0.15%⁩
Fair Value
Low confidenceCurrent price$27
Analyst target · 1 analysts
$39
⁦+47%⁩
See it clearly undervalued
Range ⁦$39–$39⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 1 analysts setting price target
$39.30
⁦+47.3%⁩
Current Price $26.68·Median $39.30
Low
$39.30
High
$39.30
Street summary

Prudential (PUK) Targets Stable Amid Limited Coverage

Bullish tilt

Prudential (PUK) stock shows complete stability in its price target at $39.3 over the past thirty days, indicating a positive price gap of 38.6% compared to the current price of $28.35. This consistency reflects a lack of dispersion among analysts, as there is only one analyst covering the price target in the current data, making the consensus lack statistical diversity despite the optimistic outlook.

As of 2026-09-03
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 4.33
Buy
Analyst coverage
3
Buy conviction
100%
High
Target dispersion
0%
Analyst ratings over time3 analysts rating
1
2
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.33 → 4.33
Recent analyst moves
  • = Reiterate2026-05-15
    Morgan Stanley
    Overweight
  • = Reiterate2026-04-23
    Morgan Stanley
    Overweight
  • = Reiterate2026-01-09
    Morgan Stanley
    Overweight
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    8.47x
    3.16x25.26x
    Cheap
  • Forward P/E
    9.66x
    2.76x22.06x
    Cheap
  • EV / EBITDA
    —
    —
  • FCF Yield
    —
    —
  • Revenue Growth YoY
    7.0%
    -36.3%104.2%
    Near median
  • EPS Growth YoY
    82.7%
    -99.4%194.2%
    Above average
  • Gross Margin
    —
    —
  • ROIC
    —
    —
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    1.1%
    0.6%9.0%
    Low
  • Payout Ratio
    18.3%
    9.8%97.8%
    Low
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-08-27 data

Company Overview

Prudential plc operates through a multi-market, multi-channel platform combining insurance and asset management in Asia and Africa. The insurance business generates value from savings, health insurance, and protection policies, while asset management benefits from fees and assets under management. The group relies on agency and bancassurance channels, with the business mix directed toward higher-margin health and protection products and faster conversion of new business profits into distributable cash surplus.

In FY 2025, revenue reached $11.5 billion, compared with $10.7 billion in FY 2024 and $9.7 billion in FY 2023. Net income increased to $4.0 billion from $2.3 billion, while earnings per share rose to 1.535 from 0.84, representing a significant improvement compared with a net loss of $1 billion and negative earnings per share of 0.368 in FY 2022.

In Q2 FY 2026 results, which covered H1 FY 2026, adjusted operating profit increased 9% to $1.81 billion, new business profit grew 8%, and adjusted operating earnings per share rose 17%. The new business margin expanded by two percentage points to 40%, total operating surplus generation increased 15%, and net operating surplus generation rose 41%, while asset management underlying profit grew 20%. In Hong Kong, the new business profit mix became evenly balanced between domestic customers and Chinese Mainland visitors, with domestic business growing 22% and its margin improving by seven percentage points.

What's Driving the Stock

  • On August 27, 2026, management maintained its guidance for double-digit growth in key financial metrics during FY 2026, despite new business profit growth of 8% in H1 FY 2026, making execution of the second-half plan a direct factor in the stock's performance.
  • Prudential is targeting more than $7 billion in shareholder returns between FY 2024 and FY 2027; it launched a $1.2 billion share buyback program to be completed by the end of FY 2026, then added approximately £0.3 billion from proceeds generated by increasing the free float of its Indian asset management business.
  • On August 24, 2026, Prudential launched Prudential HCL Health Insurance Limited in India, with HCL holding a 30% stake. The venture targets a health insurance premium market estimated at approximately $16 billion by FY 2026 and provides access to a network of more than 12,000 hospitals.
  • The reshaping of agency channels supported productivity; new business profit per active agent increased 9%, and average policy size rose 6%. Regular PRUAction 1.0 users in Singapore also achieved a productivity improvement of more than 13% within a base of 5,000 agents.
  • Management expects new business profit growth ranging from double digits to the mid-teens in growth markets during H2 FY 2026, supported by Thailand, Taiwan, Africa, and improvement in Vietnam. New business profit in ASEAN markets also grew 13% in H1 FY 2026.

Buying & Selling Case

▲ Buying Case4 pts

  • +Prudential's net income increased from $1.7 billion in FY 2023 to $2.3 billion in FY 2024 and then to $4.0 billion in FY 2025, alongside revenue growth from $9.7 billion to $11.5 billion over the same period.
  • +The quality of growth improved in H1 FY 2026; the new business margin increased to 40%, total operating surplus generation grew 15%, net operating surplus generation rose 41%, and the free surplus ratio reached 209% on June 30, 2026.
  • +Geographic and operational diversification provides more than one growth driver: domestic business in Hong Kong grew 22%, ASEAN markets increased new business profit by 13%, while asset management underlying profit rose 20% in H1 FY 2026.
  • +The capital policy combines investment with cash returned to shareholders; the group is implementing a $1 billion investment program in technology, distribution, health, and customer experience, while simultaneously targeting the return of more than $7 billion to shareholders between FY 2024 and FY 2027.

▼ Selling Case6 pts

Valuation

PUK has a consensus analyst rating of “Buy,” while its 52-week range extends from $24.61 to $34.03, a difference of $9.42 between the two limits. The improvement in earnings per share from 0.84 in FY 2024 to 1.535 in FY 2025 supports the earnings basis, but pressure on the China margin and the need to accelerate new business growth in H2 FY 2026 justify maintaining a wide valuation range. No valid price-to-earnings multiple is available within the provided data, so the assessment is based on the earnings trajectory, the 52-week range, and the “Buy” consensus.

Figures in the text are as of 2026-08-28; the live price is shown at the top of the page.

FAQ

What were Prudential's key results in Q2 FY 2026?

Q2 FY 2026 results covered H1 FY 2026 and showed a 9% increase in adjusted operating profit to $1.81 billion. New business profit grew 8%, and adjusted operating earnings per share rose 17%, while the new business margin expanded by two percentage points to 40%. Total operating surplus generation also increased 15%, net operating surplus generation rose 41%, and the first interim dividend per share increased 15%. On August 27, 2026, management confirmed its target of double-digit growth in key metrics for FY 2026.

How important is the Hong Kong business to PUK stock?

Prudential rebalanced its Hong Kong business so that new business profit is now split 50% between domestic customers and 50% between Chinese Mainland visitors. Domestic business grew 22% in H1 FY 2026, with the margin improving by seven percentage points and support from bancassurance. Health and protection products represent approximately 57% to 58% of policy count, while the retention rate reached 99%. However, the dependence of approximately half of activity on Chinese Mainland visitors keeps cross-border demand an influential factor in results.

Why were Prudential's margins in the Chinese Mainland under pressure?

The share of participating products increased from a low single-digit level to 40% in FY 2025 and then to 76% in H1 FY 2026, pressuring the margin. Bancassurance expense alignment rules also affected Q2 FY 2026 performance. Management is targeting a return of the participating product share to approximately 60% for FY 2026 after non-participating products were listed with most partner banks in August 2026. The margin target in China is approximately 40% for FY 2026, compared with 43% in FY 2025.

Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

−
The Hong Kong business depends materially on Chinese Mainland visitors, who represent approximately 50% of activity in the market, making results sensitive to visitor flows and cross-border demand. Although retention reached 99% and management observed no change in cancellation behavior through August 27, 2026, this concentration remains a significant operational risk.
  • −New business profit growth reached 8% in H1 FY 2026, below the double-digit growth guidance for FY 2026, so achieving the target requires acceleration in the second half. The company also faces high comparison bases in Hong Kong and the Chinese Mainland during July and August of FY 2026.
  • −The sharp shift toward participating products pressured the Chinese Mainland margin; these products represented 76% of the mix in H1 FY 2026, and management is targeting a reduction to approximately 60% for FY 2026. The company expects a full-year margin of approximately 40%, compared with 43% in FY 2025, with new business profit in China guided to a level similar to FY 2025 on a constant exchange rate basis.
  • −New expense rules in Chinese Mainland bancassurance caused disruption in Q2 FY 2026, while health cost-sharing rules in Singapore negatively affected margins. The recovery depends on the success of new non-participating and protection products in offsetting these regulatory pressures.
  • −The total number of active agents declined to 55,000 in H1 FY 2026, as Indonesia and the Philippines continued shifting from large-scale recruitment and part-time work toward higher-quality, full-time agents. The company improved agent productivity, but returning the total number to growth still requires successful execution in emerging ASEAN markets.
  • −The non-operating loss under IFRS reached approximately $626 million in H1 FY 2026, affected by lower interest rates and yield spreads in China and higher interest rates in other markets. Management described most of the movement as related to discount rates rather than the underlying economics, but it demonstrates the sensitivity of reported results to market movements.
  • How does Prudential plan to grow in India?

    On August 24, 2026, Prudential launched Prudential HCL Health Insurance Limited, with HCL holding a 30% stake in the venture. The business targets a health insurance premium market estimated at approximately $16 billion by FY 2026, with a network of more than 12,000 hospitals. Subject to regulatory approvals for the life insurance transaction, the group plans to combine the health and life platforms in partnership with HCL and Bharti. The five-year plan focuses on approximately 100 to 120 cities and on agency, bancassurance, digital channels, and protection products.

    How does Prudential use capital for the benefit of PUK shareholders?

    Prudential is targeting the return of more than $7 billion to shareholders between FY 2024 and FY 2027. In January of FY 2026, it launched a combined $1.2 billion share buyback program to be completed by the end of FY 2026 and added approximately £0.3 billion from measures to increase the free float of its Indian asset management business. It also expects to return an additional $1.3 billion in FY 2027. The free surplus ratio reached 209% on June 30, 2026, or 200% excluding the remaining net proceeds from the Indian offering.

    Is artificial intelligence increasing the productivity of Prudential's agency network?

    Prudential invested in technology, distribution, health, and customer experience as part of a $1 billion program. The AI-powered PRUAction 1.0 performance management system became widely used by 5,000 agents in Singapore during H1 FY 2026. Regular users achieved a productivity improvement of more than 13%, alongside a 9% increase in new business profit per active agent. However, the total number of active agents declined to 55,000, so productivity gains should be assessed alongside the company's ability to return the number to growth.